These B1L-targeted SpAcDex NPs integrated with tumors efficiently by traversing the blood–tumor barrier (BTB), upregulated PTEN expression, and caused a powerful tumor anti-angiogenic effect in experimental GBM models. Here, PTEN is linked to glioblastoma.